Nasalcrom and Nervousness - a phase IV clinical study of FDA data

Summary:

Nervousness is reported as a side effect among people who take Nasalcrom (cromolyn sodium), especially for people who are female, 60+ old, also take Singulair, and have Immunodeficiency common variable.

The phase IV clinical study analyzes which people have Nervousness when taking Nasalcrom. It is created by eHealthMe based on reports of 1,489 people who have side effects when taking Nasalcrom from the FDA, and is updated regularly.

What is Nasalcrom?

Nasalcrom has active ingredients of cromolyn sodium. It is often used in allergies. eHealthMe is studying from 1,528 Nasalcrom users. Check the latest studies of Nasalcrom.

What is Nervousness?

Nervousness is found to be associated with 1,659 drugs and 1,892 conditions by eHealthMe. Check the latest studies of Nervousness.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

1,489 people reported to have side effects when taking Nasalcrom.
Among them, 22 people (1.48%) have Nervousness.

Among these 22 people:

What is the gender of people who have Nervousness when taking Nasalcrom? *

female: 73.68 %
male: 26.32 %

What is the age of people who have Nervousness when taking Nasalcrom? *

What are other drugs people take besides Nasalcrom? *

What are other side effects people have besides Nervousness? *

Itching: 5 people, 22.73%
Blood Glucose Decreased: 5 people, 22.73%
Fever: 3 people, 13.64%
Hypoacusis (loss of hearing): 3 people, 13.64%
Breast Cancer: 3 people, 13.64%
Multiple Allergies (allergy to multiple agents): 3 people, 13.64%
Weakness: 3 people, 13.64%
Nausea (feeling of having an urge to vomit): 3 people, 13.64%
Dizziness: 3 people, 13.64%
Dyspnea (difficult or laboured breathing): 3 people, 13.64%

What are the existing conditions these people have? *

Primary Immunodeficiency Syndrome: 3 people, 13.64%
Immunodeficiency Common Variable: 3 people, 13.64%
Type 2 Diabetes: 2 people, 9.09%
Nasopharyngitis (inflammation of the nasopharynx): 2 people, 9.09%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 9.09%
House Dust Allergy: 2 people, 9.09%
Back Disorder: 2 people, 9.09%
Asthma: 2 people, 9.09%
Oedema (fluid collection in tissue): 1 person, 4.55%
Nasal Septum Perforation (hole in nasal septum): 1 person, 4.55%

* Approximation only. Some reports may have incomplete information.

Do you take Nasalcrom and have Nervousness?

- Check whether Nervousness is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Nasalcrom:

Nasalcrom (1,528 reports)

Nervousness treatments and more:

Nervousness (73,311 reports)

Browse all side effects of Nasalcrom:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Nervousness:

Nervousness (1,659 drugs)

Browse all the conditions that are associated with Nervousness:

Nervousness (1,892 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on cromolyn sodium (the active ingredients of Nasalcrom) and Nasalcrom (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.